CITADEL ADVISORS LLC 13D/13G Filings for Ikena Oncology, Inc. (IKNA)

CITADEL ADVISORS LLC 13D and 13G filings for Ikena Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
4:57 pm
Sale		 2023-12-31 13G Ikena Oncology, Inc.
IKNA		 CITADEL ADVISORS LLC 178,177
0.400%		 -1,976,957decrease
(-91.73%)		 Filing
2023-02-14
08:02 am
Purchase		 2022-12-31 13G Ikena Oncology, Inc.
IKNA		 CITADEL ADVISORS LLC 2,155,134
5.900%		 26,926increase
(+1.27%)		 Filing
2022-02-14
06:12 am
Purchase		 2021-12-31 13G Ikena Oncology, Inc.
IKNA		 CITADEL ADVISORS LLC 2,128,208
5.900%		 73,255increase
(+3.56%)		 Filing
2021-04-09
4:57 pm
Purchase		 2021-03-30 13G Ikena Oncology, Inc.
IKNA		 CITADEL ADVISORS LLC 2,054,953
6.600%		 2,054,953increase
(New Position)		 Filing